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MASTL IS THE HUMAN ORTHOLOGUE OF GREATWALL KINASE

SUMMARY
Greatwall (Gwl) was originally discovered in Drosophila as an essential kinase for correct chromosome condensation and mitotic progression. In Xenopus, Gwl may influence the positive-feedback loop that directs cyclin B1-Cdk1 activation and the mitotic state by inhibiting the phosphatase PP2A.
Here, we describe the human orthologue of Gwl called microtubule-associated serine/ threonine kinase-like (MASTL). We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active. Cells strongly depleted of MASTL by RNAi delay in G2 phase and reveal slow chromosome condensation. MASTL RNAi cells that enter and progress through mitosis often fail to completely separate their sister chromatids in anaphase. This causes chromatin to be trapped in the cleavage furrow, which may lead to formation of 4n G1 cells by cytokinesis failure. Further, our experiments indicate that MASTL supports the phosphorylation state of mitotic phospho-proteins downstream of cyclin B1-Cdk1, including the APC/C. Cyclin B1 destruction is incomplete when mitotic cells that are strongly depleted of MASTL exit mitosis. We propose that MASTL enhances cyclin B1-Cdk1-dependent mitotic phosphorylation-events, directing mitotic entry, anaphase and cytokinesis in human cells.
INTRODUCTION
Entry into mitosis requires activation of cyclin B-Cdk1. Phosphorylation of Cdk1 at Thr 14 and Tyr 15 by Wee1/Myt1 kinases restrains the activity of cyclin B1-Cdk1 complexes as they form in G2 phase. The majority of cyclin B-Cdk1 complexes is activated at the end of G2 phase by a double positive-feedback loop, in which accumulating cyclin B1-Cdk1 complexes activate the Cdk1-activating Cdc25 phosphatases, and inactivate the inhibitory Wee1 and Myt1 kinases (Lindqvist et al., 2007; Lindqvist et al., 2009 ). Active cyclin B1-Cdk1 phosphorylates a large range of substrates and triggers mitotic entry. Exit from mitosis requires cyclin B1-Cdk1 inactivation, which occurs irreversibly, by APC/C-dependent degradation of cyclin B1. Dephosphorylation of cyclin B1-Cdk1 substrates is required to leave the mitotic state and to allow it to return to interphase after division. This depends at least in part on type-1 and type-2 serine/threonine protein phosphatases (PP1 and PP2) (Chen et al., 2007; Ferrigno et al., 1993; Mayer-Jaekel et al., 1993; Mochida and Hunt, 2007; Wu et al., 2009 ). Thus far, both PP1 and PP2, and in particular PP2A, may play a role in directing mitotic exit in mammalian cells, but how their activities, or the function of the various subunits they bind to, are regulated in the cell cycle is not clear.
Interestingly, recent evidence showed that Greatwall (Gwl), a serine/threonine kinase, is a mitotic regulator that inhibits PP2A (Castilho et al., 2009; Vigneron et al., 2009; Zhao et al., 2008) . Gwl was originally identified in Drosophila to be essential for proper chromosome condensation, for progression through mitosis, and for meiosis (Archambault et al., 2007; Bettencourt-Dias et al., 2004; Yu et al., 2004) . Gwl may participate in the positivefeedback loop that controls cyclin B-Cdk1 activation by increasing Cdc25 activation (Yu et al., 2006; Zhao et al., 2008) . Experiments in Xenopus extracts, however, also indicated that Gwl-mediated inhibition of PP2A could act downstream of cyclin B1-Cdk1 activation, to maintain phosphorylation of cyclin B1-Cdk1 substrates during mitosis (Castilho et al., 2009; Vigneron et al., 2009 ). As such, Gwl could facilitate mitotic entry by lowering the threshold of cyclin B1-Cdk1 activity that must be reached before G2 cells can enter mitosis. Indeed, Gwl promotes the activation of Cdc25 in Xenopus extracts with reduced cyclin B levels and chemical inhibition of overall PP2A activity by okadaic acid can initiate mitosis before cyclin B-Cdk1 is completely active (Gowdy et al., 1998; Zhao et al., 2008) .
Eventually, PP2A inhibition can lead to a mitotic arrest, indicating that PP2A plays a role in mitotic exit events, too (Zheng et al., 1991) . However, it is unclear whether phosphatases affect cyclin B1-Cdk1 targets in a substrate-specific manner, or that phosphatase inhibition more generally supports the maintenance of the mitotic state by cyclin B1-Cdk1. Substratespecific action of mitotic phosphatases could be envisaged to coordinate events in mitotic progression, anaphase or cytokinesis. These differently timed processes all depend, at least in part, on dephosphorylation of cyclin B1-Cdk1 substrates. Changes in local phosphatase activities might help to control substrate dephosphorylation in time and space.
It is also possible that mitotic phosphatase activity is inhibited by cyclin B1-Cdk1 itself. This would lead to a 'triple positive-feedback loop' model in which cyclin B1-Cdk1 not only
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Next, we aimed to investigate the role of MASTL in mitotic entry. Therefore, we compared four independent RNAi oligos, either separately or pooled together, for their efficiencies in depleting MASTL from several human cell lines. Figures 1C and 1D show that MASTL, as detected by two different antibodies, could be specifically down-regulated by each of the siRNA oligos. RNAi-mediated knockdown was detectable 24h after transfection and persisted up to 72h. Knockdown was similarly efficient in HeLa, U2OS and HCT-116 cells ( Figures 1C and 1D ). However, we found that the mitotic phenotypes of MASTL RNAi were most pronounced in HeLa cells, which is why we used this cell line to further characterize the mitotic function of MASTL.
We found that HeLa cells released from a G1/S phase and followed by time-lapse microscopy were delayed for several hours in G2 phase before entering mitosis ( Figure  1E ). Also the timing of mitosis, as measured from the onset of chromosome condensation till initiation of anaphase in fluorescent H2B-expressing cells, was significantly increased by depletion of MASTL ( Figure 1F ). These effects of MASTL depletion are similar to the phenotypes observed in Drosophila GWL mutants, indicating that MASTL is functionally related to Gwl (Yu et al., 2004) .
MASTL is a Nuclear and Centrosomal Protein That is Active in Mitosis
In Drosophila, Gwl is found in the nucleus of interphase cells (Yu et al., 2004) . To compare the intracellular localization of MASTL with that of Gwl, we generated GFP-fusion expression constructs for human MASTL and Drosophila Gwl and followed their localization pattern in human cells as they progressed through the cell cycle. During interphase, both proteins are mainly nuclear in human cells, after which they become dispersed throughout the cytoplasm upon nuclear envelope breakdown and during mitosis ( Figure 2A , right and left panels). Confocal microscopy after cellular pre-permeabilization revealed that a fraction of GFP-MASTL is localized at the centrosomes in mitosis ( Figure 2B , right panels). Staining of endogenous MASTL by immunofluorescence (using antibody #2 and performing permeabilization prior to fixation) shows that a fraction of MASTL is localized to the centrosomes and moves to the cytokinesis cleavage furrow upon mitotic exit ( Figure 2B ). We did not observe any MASTL association with microtubule fibers of the mitotic spindle.
To analyze if MASTL is a mitotic kinase, we performed in vitro kinase assays on immunoprecipitations of either ectopically expressed GFP-MASTL or endogenous MASTL. Both precipitated proteins show a gel-shift in mitosis and phosphorylate purified Histone protein in vitro ( Figures 2C and 2D , numbers indicate quantified increase in Histone 32 P incorporation). In conclusion, these experiments suggest that MASTL is maximally active in mitosis (like cyclin B1-Cdk1) and further indicate a functional relation to Gwl.
Depletion of MASTL Results in Enhanced Phosphatase Activity
Gwl has been indicated to reduce dephosphorylation of Cdk1 by Cdc25 phosphatases, required for cyclin B1-Cdk1 activation and mitotic entry (Zhao et al., 2008) . Furthermore, loss of GWL may increase PP2A activity, leading to decreased phosphorylation of mitotic proteins (Castilho et al., 2009; Vigneron et al., 2009) . We aimed to analyze the effect of MASTL on mitotic phosphorylation in human cells. Therefore, control and MASTL RNAi cells were synchronised in G2 phase (9 hours after thymidine release) or in mitosis (12 hours after thymidine release in the presence of nocodazole; mitotic cells were collected by mitotic shake-off) ( Figure 3A) . Notably, Cdk1 was deprived of inhibitory phosphorylation in 
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Figure 1 | MASTL is the Human Orthologue of Greatwall Kinase
(A) Sequence comparison of Drosophila (Dm) and Xenopus (Xl) Greatwall protein with human (Hs) MASTL. Domains indicated in green show the strongest sequence homology between species. These parts of the protein overlap with the kinase domain, which is interrupted by the area specified in blue. The asterisk illustrates a patient mutation (E167D) found in MASTL that is correlated with the development of dominant thrombocytopenia (Gandhi et al., 2003) . (B) MASTL is modified in mitosis. RPE1 cells were synchronised with 2.5 µM aphidicolin, released into fresh medium and treated with nocodazole to obtain mitotic cells. Mitotic cells were released from the nocodazole block. Figure 3A ). This indicates that, although MASTL depletion delays mitotic entry, cyclin B1-Cdk1 is normally activated when MASTL RNAi cells enter mitosis. Total phospho-threonine content is highly increased in mitotic cells as compared to G2 cells ( Figure 3B , left panel). However, threonine phosphorylation in mitosis is strongly diminished in mitotic cells deprived of MASTL ( Figure 3B , left panel). Mitotic phospho-epitopes are also strongly decreased by depletion of MASTL, as detected by the MPM-2 antibody on Western blot ( Figure 3B , right panel). Interestingly, immunostainings reveal a loss of MPM-2 staining at the centrosomes ( Figure  3C ). Next, we analyzed the effect of MASTL depletion on phosphorylation of the APC/C subunit APC3, which is phosphorylated by cyclin B1-Cdk1 and Plk1 in mitosis (Kraft et al., 2003) . APC3 phosphorylation, as detected by gel shift, is reduced in mitotic cells depleted of MASTL, while the phosphorylation state of Cdk1 is unaffected ( Figure 3D ). Although the direct targets of MASTL kinase are currently unknown, these results suggest that mitotic phosphatase activity is enhanced upon siRNA-mediated knockdown of MASTL, antagonizing the effects of mitotic kinases such as cyclin B1-Cdk1, similar to the effects reported for GWL depletion from Xenopus extracts (Castilho et al., 2009; Vigneron et al., 2009; Zhao et al., 2008) .
Strong Depletion of MASTL Allows Mitotic Exit Before Cyclin B1 Destruction is Completed
We noticed that the effects of MASTL RNAi on mitosis and mitotic phosphorylation were strongly related to the residual levels of MASTL after RNAi treatment. Depletion of MASTL to approximately 40% of its normal levels leads to some decrease of APC3 phosphorylation in mitosis, but APC3 still remains predominantly in its phosphorylated form ( Figure 4A ), and cyclin B1 is almost completely degraded when cells are released from mitosis by adding the Cdk1 inhibitor RO-3306 to the mitotic fraction ( Figure 4A , see G1 samples). However, when MASTL is depleted to less than 15% of its endogenous levels, APC3 remains predominantly in its unphosphorylated form in mitosis, and cyclin B1 is partially stabilized when cells are released from mitosis ( Figure 4B ). Destruction of fluorescent cyclin B1 in cells that progress normally through mitosis, as measured by quantifying mCherry loss by time-lapse fluorescent microscopy, revealed that in a part of the MASTL-depleted cells cyclin B1 degradation was impaired (Figures 4C and S2) . In these cells incomplete APC/C phosphorylation, possibly as a result of more efficient MASTL depletion, may cause a delay in cyclin B1 destruction. However, it is known that expression of a non-degradable version of cyclin B1 can arrest cells in metaphase, anaphase or telophase, depending on its levels (Wolf et al., 2006) . This indicates that cells must degrade cyclin B1 to proceed through anaphase and telophase. Nevertheless, after a metaphase delay, some MASTL-depleted cells entered anaphase in the presence of residual levels of cyclin B1 ( Figures 4C and S2 ). Possibly, low levels of cyclin B1-Cdk1 activity fail to maintain MASTL-depleted cells in metaphase due to increased dephosphorylation of the cyclin B1-Cdk1 targets that prevent mitotic exit. We conclude that moderate reduction of MASTL protein levels allows normal progression through metaphase, whereas more severe depletion can cause a delay in metaphase due to incomplete APC/C activation, yet subsequently may allow exit from mitosis before cyclin B1 is fully degraded. This would fit with a model in which MASTL depletion leads to increased phosphatase activity that counteracts cyclin B1-Cdk1-dependent mitotic phosphorylation events.
MASTL Facilitates Mitotic Entry, Completion of Anaphase, and Cytokinesis
Finally, we studied the effects of MASTL depletion on sister chromatid separation, cytokinesis, and cellular survival. To facilitate efficient depletion of MASTL, we generated HeLa cell lines from which MASTL was stably knocked down by a retrovirally expressed MASTL shRNA vector (pRS-MASTL). This cell line is impaired in cell proliferation ( Figure 5A ). Analysis of the cell cycle profile by flow cytometry shows an increased 4n population, enhanced cell death (measured as subG1 cells, <2n), and strongly increased polyploidy (from 2 to 14%) (Figure To investigate in detail how MASTL depletion leads to polyploidy, we monitored mitotic progression by time-lapse imaging. We noticed a strong increase in failed cytokinesis ( Figure 5B ). Furthermore, MASTL depletion made cells more prone to death in mitosis. Although strong mitotic delay was a rare event upon MASTL depletion, a number of these cells arrested in mitosis for several hours prior to death ( Figure 5B ). To study the nature of cytokinesis failure of MASTL depletion in more detail, we transfected HeLa cells with MASTL siRNA together with a plasmid expressing H2B-RFP and filmed mitotic progression, chromosome congression and segregation. Strikingly, even in MASTL RNAi cells of which mitotic entry was normal and progressed to metaphase and initiated anaphase, we noticed that sister chromatid separation was often incomplete, leading to DNA bridges that were trapped in the cleavage furrow ( Figures 5C and 5D ). A similar phenotype was observed after depletion of ESPL1 (separase) by siRNA (Figures 5E and S3) . In a substantial fraction of the cells, the formed furrow regresses, resulting in the formation of binucleated 4n G1 cells. No obvious changes in the mitotic spindle were observed in these cells ( Figure  5D ). Cells that display DNA bridges upon MASTL depletion position the cleavage furrow normally, but are impaired in the process of abscission. This is consistent with localization of Survivin, a member of the chromosomal passenger complex (CPC), to bridged DNA ( Figure  5F ). Localization of Survivin to DNA bridges correlates with normal activity of the abscission checkpoint that acts to keep the cleavage furrow open and allows the trapped chromatin to be resolved (Steigemann et al., 2009) . However, such attempts will eventually fail in case the mass of trapped DNA is too significant to cut, eventually leading to full retraction of the cleavage furrow and formation of 4n G1 cells. In conclusion, moderate depletion of MASTL does not cause major defects in mitotic progression but can prohibit successful sister chromatid separation. This leads to significant DNA bridge formation in telophase, which may contribute to a failed cytokinesis and cause polyploidy.
DISCUSSION
MASTL is the Human Greatwall Kinase MASTL was previously shown to be an essential kinase for cell viability in HeLa cells (Iorns et al., 2009) . A functional genomic screen found MASTL as a potential determinant of taxol sensitivity and showed that depletion of MASTL induces polyploidy in the colon cancer cell line HCT-116 (Swanton et al., 2007) . Furthermore, MASTL may help to prevent thrombocytopenia (a low thrombocyte count) and is suggested to control endocytic transport (Gandhi et al., 2003; Johnson et al., 2009; Pelkmans et al., 2005) . However, no function for MASTL in the cell cycle had been described. Here, we found that MASTL is the functional orthologue of the Drosophila and Xenopus Greatwall kinases. While this manuscript was in preparation, highly similar findings were reported (Burgess et al., 2010) . We show that MASTL is a stable protein in the cell cycle that is phosphorylated and maximally active in mitosis. In agreement with this, large scale mass-spectrometry analyses of cells in mitosis identified MASTL as a mitotic phosphoprotein (Dephoure et al., 2008; Olsen et al., 2010) . Depletion of MASTL delays the G2-to-M phase transition and chromosome condensation. It remains to be tested whether this is related to impaired activation of the Cdk1 activator Cdc25, a reported effect of depletion of Xenopus Gwl from extracts (Zhao et al., 2008) . We noticed that MASTL-depleted cells that eventually enter mitosis, reveal complete Cdc25-dependent Cdk1 dephosphorylation. However, these cells were collected after mitotic delay in nocodazole, which may allow complete Cdc25 activation, leading to entire dephosphorylation of Cdk1. Single cell assays of cyclin B1-Cdk1 activation are required to reveal if MASTL depletion interferes with the onset of the positive-feedback loop in which Cdc25 is activated, or whether MASTL RNAi cells fail to enter mitosis even after cyclin B1-Cdk1 is active, due to counteracting phosphatase activity.
In line with the latter model, we found that mitotic cells depleted from MASTL exhibit a strongly reduced pattern of mitosis-specific phospho-epitopes. Although no MASTL substrates have been identified yet, we favor the idea that these mitotic phospho-proteins predominantly represent cyclin B1-Cdk1 substrates, rather than direct MASTL targets. This would indeed indicate that human MASTL inactivates a mitotic phosphatase, similar to the model proposed for Xenopus Gwl, which is suggested to inhibit PP2A (Castilho et al., 2009; Vigneron et al., 2009) . Some of the effects we report here can be reversed by the phosphatase inhibitor okadaic acid (Burgess et al., 2010) . However, given the cellular toxicity and concentration-specific effects of okadaic acid, identification of the direct substrates or binding partners of MASTL is required first to define the phosphatases or their regulatory Chapter 2 subunits acting downstream of MASTL. Nevertheless, a candidate target of MASTL might be the PP2A B-type subunit B55δ that was classified as a key phosphatase responsible for removing cyclin B-Cdk1 phosphorylations (Mochida et al., 2009) .
We found that one of the cyclin B1-Cdk1 substrates that remained incompletely phosphorylated in mitosis was the APC3 subunit of the APC/C. We also found that cyclin B1 destruction, which depends on APC/C activation, was inefficient in a subset of MASTL RNAi cells that progressed through mitosis. Depletion of MASTL might result in premature exit from mitosis by enhancing Cdk1-substrate dephosphorylation, or via direct Cdk1 inactivation by Wee1 and Myt1 kinases (Potapova et al., 2009) . Although several alternative explanations need to be investigated, this may explain why MASTL RNAi cells can exit mitosis in presence of cyclin B1, a phenomenon also known as 'pseudomitotic exit' (Castilho et al., 2009 ).
MASTL Supports Complete Sister Chromatid Separation and Cytokinesis
The distinct effects of MASTL depletion on mitotic progression were dependent on the levels of MASTL remaining after siRNA transfection. Strong reduction, generally below 15% of its normal levels in HeLa cells, correlated with a G2-to-M phase delay, a metaphase delay, and mitotic exit before complete degradation of cyclin B1. Moderate depletion of MASTL (to approximately 40%) allowed normal mitotic progression up to metaphase but correlated with incomplete separation of sister chromatids in anaphase, comparable to that seen in ESPL1 RNAi cells. Chromatin trapped in the cleavage furrow is often followed by a cytokinesis failure, which is correlated to persistent Survivin localization at the cytokinesis furrow surrounding the trapped DNA. This indicates that a significant mass of chromatin remains unseparated in anaphase after MASTL depletion, and suggests that decatenation or mitotic loss of cohesion are normally supported by MASTL. Notably, changes in the destruction rate of cyclin B1 destruction could also contribute to a cytokinesis defect, independently of DNA bridge formation. These possibilities are being further investigated.
Redundancy of MASTL or Phosphatase Activities
Although we universally detect MASTL activation in mitosis, and were able to deplete MASTL highly efficiently from a range of cell lines, the phenotypes we report here for MASTL depletion were most clearly detected in HeLa cells. We cannot exclude that residual levels of MASTL after siRNA depletion prevented detection of strong mitotic phenotypes in other cell lines. Alternatively, intrinsic phosphatase activities are cell-type specific and determine the effect of MASTL interference. Further, cells may be able to compensate for loss of MASTL, for instance by feedback mechanisms that reduce the activity or expression levels of phosphatases and/or their regulatory pathways, or that increase cyclin B1 levels. Similarly, stable knockdown of the PP2A subunit B56δ, resulting in prolonged hyper-phosphorylation of Cdc25C and dephosphorylation of Cdk1, induces adaptation by upregulation of Wee1 (Forester et al., 2007) . The same is true for B56δ knockout mice, which do not have an obvious phenotype. Further insight in the roles of Gwl in mammalian cells awaits the identification of its substrates and the signaling pathways by which it may interfere with cyclin B1-Cdk1-mediated events.
EXPERIMENTAL PROCEDURES
Cell culture, Synchronization, and Transfection HeLa, U2OS, RPE1, HCT-116 or Phoenix-ECO (expressing gag-pol and an ecotropic envelope protein) cells were cultured in DMEM supplemented with 8% heat-inactivated foetal bovine serum, penicillin (100 U/ml), and streptomycin (100 µg/ml) at 37°C in 5% CO 2 . Cells were plated on glass bottom dishes (Willco Wells) or 9 cm Falcon dishes 24-48 hours prior to synchronization. HeLa and U2OS cells were synchronized using a 24 hours thymidine block and RPE1 cells with an aphidicolin block. To obtain cells enriched in G2 phase, cells were incubated for 9 hours after release from a G1/S phase block. To arrest cells in mitosis, nocodazole (830 nM final concentration) or paclitaxel (1 µM final concentration) was added 9 hours after release from the G1/S phase block for an additional 12 hours or overnight. Mitotic cells were harvested by gentle mitotic shake-off (Lindqvist et al., 2007) . To obtain G1 phase cells, mitotic cells were released from nocodazole or treated with 10 µM of the Cdk1 inhibitor RO-3306 as indicated in the figure legends. To obtain spindle checkpointinactivated mitotic cells, the mitotic cells were released from a nocodazole arrest in the presence of 5 µM MG132.
For time-lapse experiments, cells on Willco Wells dishes were transfected with 50 nM of siRNA or 0.1 µg of expression plasmids as indicated, using the transfection reagent Lipofectamine 2000 (Invitrogen). U2OS cells were co-transfected on 9 cm Falcon culture dishes, using 1 µg of expression plasmids as indicated together with 1 µg of pBABE-Puro by the calcium phosphate transfection method and selected with puromycin for 24 hours (in the presence of thymidine). Specific protein expression was assayed by immunoblotting. MASTL in vitro kinase assays were performed on anti-GFP or anti-MASTL immunoprecipitates incubated with 32P-γATP for 30 min with Histone H1 or Histone H3 as substrate. Samples were assayed by SDS-PAGE and subjected to Western blotting. Blots were exposed by using a phosphorimager screen. For quantification, intensities were measured and background was subtracted using Tina and Excel. The weakest signal (beads only control) was used for calculation of the relative difference (ratio) between every lane. RNAi experiments in 6-well and 9 cm dishes were performed using 50 nM of single or pooled siRNA oligos targeting the human proteins as indicated. siCTRL refers to 1x siRNA buffer. Transfections were performed with Lipofectamine 2000 in Optimem (Invitrogen) medium. For sequential depletion experiments, the second siRNA transfection was performed 24 hours after the initial transfection.
Ecotropic Phoenix cells were transfected with 20 µg of pRETRO-SUPER.Puro vector using calcium phosphate precipitation. Retroviral supernatant was collected 2 times, both 40 and 48 hours after transfection and was cleared through a 0.45 µM filter (Millipore). HeLa cells
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expressing the ecotropic receptor (HeLa-ECO) were infected twice with retroviral supernatant and cultured for 2 days to allow retroviral integration and efficient gene targeting. Infected cells were then selected for 48 hours with puromycin to obtain a polyclonal pool of stable knockdown cells.
Plasmids and RNAi
MASTL and Drosophila Gwl cDNA were purchased from http://plasmid.med.harvard.edu and http://flybase.org, PCR amplified and cloned into pEGFP-C1 using HindIII/KpnI or KpnI/SacI digestion, respectively. Full length cyclin B1 cDNA was cloned into pEGFP-N1 wherein the GFP was replaced by a modified mCherry. pBabe-puro, Histone H2B-CFP, and Histone H2B-RFP have all been described (Brummelkamp et al., 2002; Kanda et al., 1998) . The MASTL targeting vector (pRS-MASTL) was based on a 19-mer sequence present in the coding sequence of human MASTL (5'-GGACAAGTGTTATCGCTTA-3'). Synthetic 64-mer oligonucleotides for cloning into pRETRO-SUPER.Puro were synthesized, annealed and ligated into EcoRI/XhoIdigested pRETRO-SUPER.Puro construct. All plasmids were sequence verified. siRNAs to target MASTL or ESPL1 were purchased from Dharmacon as set of 4 individual ON-TARGETplus oligos as described in the supplemental experimental procedures (Table S1 ). 
SUPPLEMENTAL FIGURE LEGENDS
Antibodies, Dyes, and Chemicals
The following antibodies were used: goat anti-Actin (Santa Cruz), mouse anti-α-Tubulin (Sigma), mouse anti-APC3 (BD Transduction), mouse anti-Cdk1 (Cell Signaling), rabbit anticyclin A2 (Santa Cruz, H-432), mouse anti-cyclin B1 (Santa Cruz, GNS1), rabbit anti-γ-Tubulin (Santa Cruz, H-183), rabbit anti-geminin (Santa Cruz, FL-209), rabbit anti-GFP (generated by immunizing rabbits, following affinity purification), rabbit anti-MASTL (Abcam), rabbit anti-MASTL (Bethyl), mouse anti-MPM-2 (Millipore), rabbit anti-phospho-Threonine (Cell Signaling), rabbit anti-securin (Zymed), and rabbit anti-Survivin (R&D Systems).
Secondary peroxidase-conjugated anti-rabbit, anti-mouse, and anti-goat antiserum were obtained from DAKO. ALEXA fluorescently-labelled secondary anti-mouse/Alexa488, Gwl/ MASTL NM_032844 J-004020-12 CCAUUGAGACGAAAGGUUU siRNA targeting sequences used for transient knockdown were purchased from Thermo Fisher Scientific as set of four individual ON-TARGET-plus oligos.
SUPPLEMENTAL INFORMATION SUPPLEMENTAL EXPERIMENTAL PROCEDURES
SUPPLEMENTAL FIGURE LEGENDS
Figure S1 | MASTL is Phosphorylated in a Cyclin B1-Cdk1-Dependent Manner U2OS cells synchronised with thymidine and nocodazole were released from the nocodazole block and released into fresh medium containing indicated drugs. Cell extracts were processed for Western blot.
Figure S2 | Destruction of Ectopic Cyclin B1 is Impaired After Knockdown of MASTL
anti-rabbit/Alexa568, and anti-mouse/Alexa568 were purchased from Molecular Probes. Propidium iodide (PI) was from Sigma and 4',6-Diamidino-2-phenylindole (DAPI) from Molecular Probes.
The following chemicals were used: okadaic acid (LC Laboratories), NSC 662384 (Tocris), RO-3306 (Calbiochem), AZD1152 (AstraZeneca), MG132, aphidicolin, nocodazole, paclitaxel, and flavopiridol (all purchased from Sigma).
Immunoprecipitations and Western Blots
Cells were lysed in ELB+ (150 mM NaCl, 50 mM HEPES (pH 7.5), 5 mM EDTA, 0.3% NP-40, 10 mM β-glycerophosphate, 6% glycerol, 5 mM NaF, 1 mM Na3VO4, and Roche protease inhibitor cocktail). Lysates were cleared by centrifugation (13,000 × g, 8 min at 4°C). Protein levels were equalized by using Bradford analysis. For immunoprecipitations, 1-2 μg antibodies were precoupled for 4-12 hours to 20 μl of protein G Sepharose (Amersham Biosciences) and washed with ELB+. Precoupled beads and lysates were incubated overnight at 4°C and washed four times with 1.2 ml of ice-cold ELB+. All remaining buffer was then removed, and beads were resuspended in 50 μl sample buffer; 25 μl was separated on SDS-PAGE and blotted. ) containing 2% bovine serum albumin and labeled with primary antibodies as indicated. Cells were washed 3 times followed by labeling with Alexa Fluor secondary antibodies. DNA staining was performed with DAPI after which the coverslips were mounted in Vectashield solution. For endogenous MASTL staining, cells were pre-permeabilized for 3-5 min in PHEM buffer (100 mM PIPES pH 6.8, 25 mM HEPES pH 7.4, 5 mM EGTA, 2.5 mM MgCl 2 ) plus 0.5% Triton X-100. Then, cells were fixed for 10 min in PHEM buffer containing 3.7% formaldehyde. Subsequent steps were performed as described above. z-stacks with 0.2-μm spacing were acquired using a Leica AOBS confocal microscope. Maximum intensity projection of the z-levels were analyzed with MetaMorph 7.7 and Adobe Photoshop CS3 software.
Immunofluorescence
Cells were grown on glass coverslips and fixed with PBS (Ca
Time-Lapse Microscopy
HeLa cells transfected with siRNA and indicated constructs were followed by time-lapse fluorescence microscopy as previously described (Di Fiore and Pines, 2007; Lindqvist et al., 2007) . For quantitative analysis of cyclin B1-mCherry degradation, all parameters were fixed within the experiment. Time-lapse images were processed by using MetaMorph imaging software 7.7 for Windows XP. A region was drawn around the edge of the entire cell (for the background, a region was drawn near the cell), the mean pixel intensity was calculated, and To monitor mitotic entry, HeLa cells were transfected in 6-well plates with indicated siRNA oligos, synchronized with thymidine, and released in fresh medium containing paclitaxel and drugs as indicated. Live cells were maintained in a climate-controlled culture chamber at the stage of a Zeiss Axiovert 200 M inverted microscope connected to Zeiss AxioCam Black and White camera. Acquisition of phase contrast images started 48h after transfection. Images were captured by Zeiss Axiovision software and analyzed using MetaMorph and Excel software.
SUPPLEMENTAL FIGURES
Chapter TWO | Figure S1 The decision to enter mitosis relies on the activation of cyclin B1-Cdk1 and the simultaneous inhibition of the Cdk1-antagonizing phosphatase PP2A. Here, we provide evidence that inactivation of this phosphatase requires the well-conserved Greatwall/MASTL targets α-Endosulfine (Ensa) and cAMP-regulated phosphoprotein 19 (Arpp19). In human cells, the evolutionary conserved Greatwall phosphorylation site in both proteins is crucial for their conversion into PP2A inhibitors. We demonstrate that mutation of a single serine residue markedly changes their ability to bind PP2A. Depletion of ARPP19 and ENSA by RNAi moderately increases the incidence of DNA bridges during anaphase. The localization of these proteins perhaps suggests that PP2A is regulated locally, at the midbody, in order to maintain intercellular connectivity when anaphase bridges are present.
INTRODUCTION
Cyclin B1-Cdk1 complex are formed in G2 phase, but are kept mostly inactive due to the inhibitory phosphorylations. Once these inhibitory phosphorylations are removed, cyclin B1-Cdk1 activity increases progressively. In order to phosphorylate and subsequently maintain stable substrate phosphorylation, cyclin B1-Cdk1 must overcome the inhibitory actions of PP2A-B55, the main Cdk1 antagonist (Mochida and Hunt, 2012) . The activity of PP2A-B55 is inversely correlated with that of cyclin B1-Cdk1, since PP2A-B55 is turned off as soon as cyclin B-Cdk1 is turned on. This cell cycle regulated inactivation of PP2A is brought about by a kinase called Greatwall (Gwl)/MASTL (Burgess et al., 2010; Castilho et al., 2009; Vigneron et al., 2009; Voets and Wolthuis, 2010; Zhao et al., 2008) . Data from different model systems demonstrate that Gwl is part of the double positive-feedback loop required to activate cyclin B1-Cdk1 at the end of G2 phase. Gwl itself is a cyclin B1-Cdk1 substrate (Álvarez-Fernández et al., 2013; Wang et al., 2013) , that becomes fully active by further autophosphorylation (Blake-Hodek et al., 2012) . Active Gwl directs the inhibition of PP2A-B55 via the phosphorylation of two small homologous proteins belonging to Endosulfine family. These PP2A inhibitors, better known as Arpp19 and Ensa, support the full repertoire of cyclin B-Cdk1 substrate phosphorylations (Gharbi-Ayachi et al., 2010; Mochida et al., 2010) . Gwl mediates the phosphorylation of Arpp19 and Ensa at a single serine residue, which specifically changes their affinity for PP2A-B55 (Mochida, 2014). These findings have been extended from frogs to lower organisms (Bontron et al., 2013; Juanes et al., 2013; Kim et al., 2012; Rangone et al., 2011; Talarek et al., 2010; Wang et al., 2011) , but so far experimental data from mammalian cells is lacking. Here, we characterized the contribution of Arpp19 and Ensa to mitosis in human cells. We demonstrate that both proteins function as PP2A inhibitors and that this requires the conserved Gwl phosphorylation site. We conclude that MASTL-mediated PP2A inactivation directs cyclin B1-Cdk1 phosphorylations, necessary to prevent errors during mitosis.
RESULTS
The Gwl Substrates Arpp19 and Ensa are Involved in PP2A Inhibition in Mitosis
Control of mitotic PP2A-B55 activity is thought to involve two related proteins termed Arpp19 and Ensa (Gharbi-Ayachi et al., 2010; Mochida et al., 2010) . Multiple sequence alignment of the human variants of Arpp19 and Ensa reveals that both proteins are highly similar and contain multiple phosphorylation sites ( Figure 1A) . At least one of these residues is phosphorylated by cAMP-activated protein kinase (PKA) (Mochida et al., 2010) , whereas a single evolutionary conserved phosphorylation site (Ser 62 and Ser 67 in App19 and Ensa, respectively) is phosphorylated by Gwl. These proteins are remarkably similar in that they are both detected by Western blot using a rabbit polyclonal anti-Arpp19 ( Figure 1B) . Since Arpp19 and Ensa differ in their N-terminus, only an antibody that is directed against this part of either protein will be able to discriminate between the both ( Figure 1B , anti-Ensa AA [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] ).
Like in Xenopus extracts, we observed that human Ensa is more prominently abundant than human Arpp19. Since the contribution of both human Arpp19 and Ensa in the regulation of PP2A has not yet been addressed, we tested the effects of their depletion by RNAi. As expected, depletion of MASTL severely impaired the phosphorylation status of cyclin B1-Cdk1 substrates (25% of control), as observed by the quantification of the phospho-serine signal intensity ( Figure 1C) . Silencing of either ARPP19 or ENSA also reduced cyclin B1-Cdk1 substrate phosphorylation, albeit to a lesser extent (54% and 65% of control, respectively). However, combined depletion of MASTL and either ARPP19 or ENSA further suppressed cyclin B1-Cdk1 activity (30% of control in both conditions). Western blotting verified that we were able to efficiently deplete these proteins from cycling cells ( Figure 1D ). Together, these results indicate that, unlike the depletion of MASTL, RNAi of ARPP19 or ENSA alone is insufficient to completely relieve PP2A inhibition. Since both proteins appear very similar, it is likely that their combined depletion may actually increase PP2A activity similar to knockdown of MASTL.
MASTL Changes the Binding Affinity of Arpp19 and Ensa for PP2A
A multi-species comparison of the Gwl phosphorylation site in Arpp19 and Ensa shows that the phosphorylated residue is part of a highly conserved motif (Figure 2A) . We further tested whether Arpp19 and Ensa may also interact with PP2A in human cells, by immunoprecipitating endogenous PP2A-Cα ( Figure 2B ). We find that endogenous Ensa, but not Arpp19, appears to bind PP2A and that this interaction is restricted to mitosis. Moreover, our data indicates that the Ensa-PP2A interaction depends on the presence of MASTL, since MASTL RNAi impairs their interaction. We generated Venus-tagged variants of Arpp19 and Ensa to address the relevance of the conserved Gwl phosphorylation site. Therefore, we specifically mutated the Ser 62 and Ser 67 to either Ala (A) or Asp (D). Again, we did not detect a physical interaction between wild-type (WT) Arpp19 and endogenous PP2A ( Figure 2C ). However, the phosphomimetic Ser 62 Asp (SD) Arpp19 constitutively bound to the PP2A-Cα subunit, which was not observed when Ser 62 was mutated to Ala (SA). Perhaps the interaction between WT Arpp19 and PP2A is rather weak, for example due to continuous dephosphorylation of the Gwl site. We also tested the binding of WT and Ser 67 site mutants of Venus-tagged Ensa to endogenous PP2A ( Figure 2D) . Again, the phosphomimetic mutant bound constitutively to PP2A-Cα, regardless of the mitotic state. The position of the Venus tag (e.g. N-terminal or C-terminal) did not influence the PP2A binding potential of Ensa. Here, WT Ensa did interact with endogenous PP2A-Cα, which was enriched in mitosis and in line with previous results (Figures 2B and 2D) . The SA mutant of Ensa did not bind to PP2A, indicating that the Ser 67 phosphorylation site is indeed required to convert Ensa into a potent PP2A inhibitor, similar to the observations made with Drosophila proteins (Kim et al., 2012) .
To further prove the functionality of these phospho-regulated proteins as potent PP2A inhibitors, we developed an assay that measures cell viability when Cdk1 activity is Protein alignment S2 S46 T88 T94 S104 S62 Gwl S108 PKA Endogenous Ensa is recognized by the rabbit polyclonal anti-Arpp19. U2OS cells stably infected with indicated shRNAs were synchronised in G2 phase and mitosis using thymidine and taxol. Cells arrested in mitosis were obtained by mitotic shake-off and lysed directly or subsequently treated with 10 μM of RO-3306 for 3 hours to obtain G1 phase cells. Extracts were processed for Western blot analysis and blotted for the proteins as indicated. (C) Human Arpp19 and Ensa contribute to PP2A inhibition in mitosis. HeLa cells transfected with indicated siRNA pools were synchronised in mitosis by a thymidine block followed by subsequent taxol treatment. Cells arrested in mitosis were collected by mitotic shake-off. Extracts were processed for Western blot analysis 64 hours after the siRNA transfection and blotted for the proteins as indicated. The intensity of the p-Serine signal was quantified for each individual lane of the gel and corrected for the Actin loading control. (D) Silencing of the human variants of ARPP19 and ENSA by RNAi. Asynchronously growing HeLa cells were transfected with either a control RNAi (siCTRL) or with a siRNA pool targeting MASTL, ARPP19, or ENSA and processed for Western blotting 48 hours after the transfection. Extracts were blotted for the proteins as indicated.
compromised ( Figure 2E ). Long-term suppression of Cdk1 by the small-molecule inhibitor RO-3306 inhibits cell proliferation in multiple cell lines. Remarkably, we find that overexpression of Ensa WT , but not the phosphomimetic Ensa S67D , allows cell proliferation in presence of RO-3306, similar to knockdown of PPP2CA (Figures 2E and 2F ; data not shown). We believe that the Ser 67 Asp mutation prevents dynamic regulation of Ensa by MASTL, and perhaps also other kinases, which may be vital for its effectiveness as a mitotic PP2A inhibitor. Moreover, continuous PP2A inhibition may negatively affect normal cell cycle progression.
Collectively, these data demonstrate that Arpp19 and Ensa may function as PP2A inhibitors in human cells, too. Furthermore, mutation of the Gwl phosphorylation site provides evidence that MASTL may phosphorylate both Ensa and Arpp19, converting them in the potent PP2A inhibitors required to support cyclin B1-Cdk1 substrate phosphorylation in mitosis.
MASTL Directs Normal Anaphase Progression and Cytokinesis
We investigated the localization of Arpp19 and Ensa in order to gain more insight into their mode of action. Since our Arpp19 antibody recognizes both endogenous Ensa and Arpp19 ( Figure 1B) , we studied the localization of ectopic Arpp19-Venus WT and compared this to endogenous Ensa. As observed, Arpp19 and Ensa are predominantly nuclear in interphase, while they show a diffuse pattern in mitosis ( Figure 3A) . We noticed that both proteins are excluded from the chromatin in mitosis. After mitotic exit, their localization in the nucleus re-appeared, with a fraction of the proteins being present at the midbody. Speculatively, this midbody-restricted fraction of Arpp19 and Ensa may contribute to localized PP2A regulation.
Next, we tested the effects of ARPP19 and ENSA suppression on mitosis by time-lapse imaging of HeLa cells expressing H2B-mCherry. We compared the effects of MASTL RNAi with that of either siCCNB1, or a combination of ARPP19 and ENSA RNAi ( Figure 3B ). As expected, suppression of MASTL resulted in the formation of chromatin bridges in anaphase. Efficient depletion of ARPP19 and ENSA on the other hand only slightly increased the incidence of anaphase bridges ( Figures 3B and 3C) . Interestingly, knockdown of CCNB1 allowed cells to enter mitosis, but often caused lagging chromosomes in anaphase, which, in some cases, resulted in the formation of DNA bridges. As expected, the effects of CCNB1 RNAi appear more severe than depletion of MASTL alone, or its targets ARPP19 and ENSA. These results confirm that cells can traverse through mitosis with decreased levels of cyclin B1-Cdk1 activity, and that this severely impacts mitotic exit.
To investigate whether DNA bridges contained unseparated sister chromatids, MASTL RNAi cells were stained with DAPI and CREST ( Figure 3D ). Representative examples of anaphase and telophase cells demonstrate that the DNA bridges, arising after MASTL depletion, are typically devoid of CREST-positive centromeres. We further tested the localization of other proteins which may clarify the origin of the DAPI-positive anaphase bridges. One of these proteins include the rDNA marker UBF ( Figure 3E) . In mitotic cells, UBF localizes in a focal pattern, which re-localizes to the nucleoli in G1 phase where it regulates 
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C T R L V e n u s -E n s a W T V e n u s -E n s a SD C T R L V e n u s -E n s a W T V e n u s -E n s a SD C T R L V e n u s -E n s a W T V e n u s -E n s a SD kDa Actin 50 rDNA transcription (Bell et al., 1997) . DNA bridges were negative for localized UBF, indicating that chromosome bridging is independent of rDNA sequences. Taken together, our results indicate that DNA bridges, arising in anaphase, may be prevented by the action of MASTL and its effectors in order to keep PP2A in check. Local PP2A inhibition could be a mechanism to maintain intercellular connections at the spindle midzone and prevent DNA breakage once DNA ends up in the cleavage furrow ( Figure 3F ). Subsequent resolution of anaphase bridges ensures successive cell cycle progression.
DISCUSSION
In this study we have provided evidence that MASTL, the mammalian orthologue of Gwl kinase, directs the inhibition of PP2A in mitosis. We demonstrate that, also in human cells, MASTL may function together with the small phospho-regulated proteins Arpp19 and Ensa.
Recent findings have provided evidence that MASTL functions downstream of cyclin B1-Cdk1 (Álvarez-Fernández et al., 2013; Wang et al., 2013) . Just after cyclin B1-Cdk1 translocates to the nucleus in prophase, MASTL is exported to the cytoplasm. This nucleo-cytoplasmic shuttling depends exclusively on Cdk1-mediated phosphorylation of MASTL, at least in mammalian cells, whereas in Drosophila Plk1 seems to play a role in MASTL localization, too. Also, the kinase activity of MASTL itself is needed in order to shuttle to the cytoplasm. Furthermore, MASTL possesses two nuclear localization signals (NLSs), which have been proven to be functional for its nuclear localization in interphase.
Many potential phosphorylation sites can be found in MASTL, but it is thought that at least Thr 194 and Thr
207
, fitting the cyclin-Cdk target consensus, are essential for its activation in mitosis (Blake-Hodek et al., 2012) . In addition, phosphorylation of Ser 875 is crucial for maintaining MASTL activity (Blake-Hodek et al., 2012; Vigneron et al., 2011) . Since this residue does not fit any known kinase consensus, it is hypothesized that MASTL itself may be the responsible kinase to phosphorylate Ser 875 . This would also support the observation that MASTL needs its kinase activity in order to localize to the cytoplasm in prophase.
Whether Arpp19 and Ensa follow a similar change in localization after MASTL activation, is currently unknown. We find that both proteins are predominantly nuclear in interphase, comparable to MASTL. Unlike MASTL, Arpp19 and Ensa did not concentrate at centrosomes in mitosis (Burgess et al., 2010; Hégarat et al., 2014; Voets and Wolthuis, 2010) , but localized to the midbody during mitotic exit. Possibly, these proteins may locally inhibit PP2A at this stage, for example to prevent abscission when chromatin is trapped in the cleavage furrow (Norden et al., 2006) . This checkpoint, safeguarded by Aurora B (Steigemann et al., 2009) , perhaps requires other factors that possess the ability to inhibit counteracting phosphatase activity.
Since the PP2A-B55 complex mostly resides in the cytoplasm, it is thought that the nuclear export of MASTL is critical to inhibit cytoplasmic PP2A activity (Ohkura et al., 1994; Santos et al., 2012) . Alternatively, the nuclear localized MASTL may escape inactivation by PP2A, as the PP2A-B55 complex is able to dephosphorylate the critical Thr 194 of MASTL (Hégarat et al., 2014) . It is unclear whether Arpp19 and Ensa follow a similar localization pattern as MASTL. In budding yeast, regulation of PP2A-B55 is executed by the Arpp19 and Ensa orthologs Igo1 and Igo2 (Bontron et al., 2013; Juanes et al., 2013; Talarek et al., 2010) . Both Igo1 and Igo2 control the subcellular localization of PP2A-B55 by promoting its nuclear exclusion during mitotic entry (Juanes et al., 2013) . This may depend on direct phosphorylation by Gwl.
Remarkably, we find that only Ensa, but not Arpp19, binds PP2A specifically in mitosis. It is possible that the levels of endogenous Arpp19 fall short of the detection limit, while the protein levels of Ensa are more prominent and therefore easier to recognize. However, we also did not observe an interaction between PP2A and immunoprecipitated Arpp19-Venus. We therefore think that Ensa may be the principal PP2A inhibitor in human cells. We do find that the phosphorylation of Arpp19 and Ensa on Ser 62 and Ser
67
, respectively is critical for their function. Phosphomimetic mutants of both proteins convert them into potent PP2A binding partners, while phospho-dead mutants almost completely abolish their interaction with PP2A (Gharbi-Ayachi et al., 2010; Kim et al., 2012; Mochida et al., 2010) . The phosphorylation of a single serine in these proteins appears sufficient to promote their interaction with PP2A. Yet, additional phosphorylation sites are present, which may also have a regulatory function (Mochida, 2014) . Interestingly, Cdk1 may also directly phosphorylate Arpp19, at least in starfish oocytes, functioning as a Gwl-independent route (Okumura et al., 2014) . Once phosphorylated, Arpp19 and Ensa are thought to bind PP2A at the interphase of the catalytic (PP2A-Cα) and the B-subunit (B55). As a result, they may directly inhibit the catalytic activity of the specific B55-type complex.
Chapter 2
Addendum
In contrast to Gwl, active Arpp19 and Ensa are not dephosphorylated by PP2A-B55. Instead, the RNA Polymerase II carboxy terminal domain phosphatase Fcp1 appears to dephosphorylate the Gwl phosphorylation site during exit from mitosis (Hégarat et al., 2014) . This phosphatase is thought to mediate exit from mitosis by reversing the phosphorylation of particular mitotic substrates (Visconti et al., 2012) . Perhaps Fcp1 becomes active prior to PP2A-B55 in order to dephosphorylate Arpp19 and Ensa. As a result, this would relieve PP2A inhibition and mediate mitotic exit by the joint action of these, and possibly other, phosphatases.
We expected that the effects of ARPP19 and ENSA co-depletion would completely resemble that of MASTL RNAi. Remarkably, we observed that depletion of these proposed Gwl targets only moderately affected mitotic exit in human cells. In other organisms, such as D. melanogaster, a single orthologue of X. laevis Arpp19 and Ensa, termed Endos, is able to direct all Gwl-mediated processes. Suppression of Endos results in spindle defects and aberrant mitotic exit, similar to GWL RNAi (Rangone et al., 2011; Von Stetina et al., 2008) . Interestingly, the C. elegans genome has no obvious Gwl orthologues, but it does have a single Endos gene whose product retains the Gwl phosphorylation site. However, mutation of this phosphorylation site does not disrupt cell cycle progression (Kim et al., 2012) . We believe that mammals perhaps require additional factors that act as PP2A inhibitors. With the recent advances in technologies for genome editing, it will be interesting to examine the consequence of ARPP19 and ENSA gene knockouts in cultured cells. If ARPP19/ENSA double knockout cells do not phenotypically resemble the MASTL knockout cells (Álvarez-Fernández et al., 2013) , we believe that mammals may possess more Arpp19/Ensa-like substrates that are yet to be identified.
EXPERIMENTAL PROCEDURES
Cell Culture and Synchronization HeLa-ECO (expressing the ecotropic receptor), RPE1-ECO, U2OS-ECO, and Phoenix-ECO or Phoenix-AMPHO cells (expressing gag-pol and an amphotropic or ecotropic envelope protein) were cultured in DMEM (Gibco) containing 8% heat-inactivated FBS (Hyclone) supplemented with 100 U/ml penicillin and 100 µg/ml streptomycin at 37°C in 5% CO 2 . 24 or 48 hours before synchronization, transfection or treatment, cells were seeded on either 6-well Costar plates or 9 cm Falcon dishes. For time-lapse fluorescence microscopy, cells were seeded onto 4-well glass-bottom dishes (Labtek II). For enrichment of cells in mitosis, cells were treated for 16-24 hours with thymidine (T1895, 2.5 mM final concentration [Sigma-Aldrich]), released into fresh medium and subsequently treated with nocodazole (830 nM final concentration [Sigma-Aldrich]) or taxol (500 nM final concentration [SigmaAldrich]) for 16 hours. Mitotic cells were collected by mitotic shake-off. For G1 phase synchronisations, mitotic cells were refreshed with medium containing RO-3306 (#217699, 10 µM final concentration [Calbiochem] ). G2 phase cells were collected 9 hours after release from a thymidine block, after washing away any early mitotic cells.
Long-Term Cell Proliferation Assays
Cells were seeded into 6-well plates (5*10 3 cells per well) and cultured both in the absence or presence of RO-3306 as indicated. Within each cell line, cells cultured at different conditions were fixed with 3.7% formaldehyde (in PBS) at the same time. Afterwards, cells were stained with 0.1% crystal violet (in water).
Plasmids and siRNA Human ARPP19 cDNA was purchased from Source Bioscience and human ENSA cDNA was PCR amplified from a human cDNA library generated from RPE-1 cells, respectively. The ARPP19 cDNA was PCR amplified from pCMV-SPORT6-ARPP19 and the product was subcloned into pEGFP-N1 using EcoRI/KpnI digestion. The ENSA PCR product was subcloned into both pVenus-C1 and pVenus-N1 (Takara Bio Inc.) using EcoRI/SalI digestion. The viral plasmids pLIB-ARPP19-Venus, pLIB-ENSA-Venus, and pLIB-Venus-ENSA were constructed by subcloning the inserts into a modified pLIB vector denoted as pLIB-N1 or pLIB-C1. The phosphorylation mutants of ARPP19 (Ser 62 site) and ENSA (Ser 67 site) were made by sitedirected mutagenesis using the ARPP19-Venus, ENSA-Venus, or Venus-ENSA DNA as a template. All plasmids were sequence verified.
Synthetic 64-mer oligonucleotides for cloning into pRetroSuper.puro were synthesized, annealed and ligated into EcoRI/XhoI-digested pRetroSuper.puro construct. For the generation of knockdown vectors targeting human ARPP19 and ENSA, the 19-nucleotide sequences were used as described in the supplemental experimental procedures (Table S1 ). The siRNAs to target ARPP19, CCNB1, ENSA, and MASTL were purchased from Thermo Fisher Scientific as set of four individual ON-TARGET-plus oligos as described in the supplemental experimental procedures (Table S2) . 
